Полиморфизмы С-33Т, С-590Т, G-1098Т в промоторе гена ИЛ-4 при атопической бронхиальной астме
Диссертация
2. Влияние полиморфизма С-ЗЗТ на уровень сывороточного ИЛ. Исследование полиморфизма G-I098T у больных бронхиальной астмой.62 4.4.1.Частота выявления мутантного аллеля4. 4. 2. ОпределениеЕ и ИЛ. 3. Полиморфизм С-590Т и тяжесть течения заболевания. Глава 4. Собственные исследования4. 1. Характеристика групп больных бронхиальной астмой на основании клинико-иммунологического исследования. Глава 2… Читать ещё >
Список литературы
- Баранов B.C., Баранова Е. В., Иващенко Т. Э., с соавт. Геном человека и гены «предрасположенности» (Введение в предиктивную медицину).// СПб.-Интермедика. — 2000. — С. 272.
- Гриппи М. А. Патофизиология легких. М. — Восточная книжная компания. — 1997. — С. 344.
- Гущин И.С. Физиология иммуноглобулина Е. // Аллергология и Иммунология 2000. — Т. I. — № 1. — С. 76−88
- Иващенко Т.Э., Сиделева О. Г., Петрова М. А. с соавт. Генетические факторы предрасположенности к бронхиальной астме.//Генетика. 2001.- Т. 37. — С. 107−111.
- Колчанов Н. А., Ананько Е. А., Колпаков Ф. А. с соавт. Генные сети.// Молек. биол. 2000. — Т. 34. — № 4. — С. 533−544.
- Ляхович В. В., Вавилин В. А., Макарова С. И. с соавт. Роль ферментов биотрансформации ксенобиотиков в предрасположенности к бронхиальной астме и формировании особенностей ее клинического фенотипа.// Вестн. РАМН 2000. -№ 12. — С. 36−41.
- Пузырев В. П., Степанов В. А. Патологическая анатомия генома человека.// Новосибирск: Наука 1997. — С.224.
- Резник И.Б. Генетические механизмы развития бронхиальной астмы.// Аллергология 1998. — Т1. — С. 5−12.
- Украинцева С. В., Сергеев А. С. Популяционный риск возникновения бронхиальной астмы в Москве // Генетика 1995. -Т. 31. -№ 2. — С. 264−267.
- Ю.Флелс Дж. Статистические методы для изучения таблиц долей и пропорций. // М.: Финансы и статистика 1989. — С. 319.
- П.Фрейдин М. Б., Брагина Е. Ю., Огородова Л. М., с соавт. Полиморфизм генов глугатионтрансфераз тета1 и мю1 (GSTTI и GSTM1 у больных атонической бронхиальной астмой в Западносибирском регионе// Молекулярная биология 2002. — Т. 36. — № 4. — С. 630−634
- Фрейдин М. Б., Кобякова О. С., Огородова Л. М. с соавт. Наследуемость уровня общего интерлейкина-5 и полиморфизм С-703Т гена ИЛ5 у больных бронхиальной астмой.// Бюлл. эксп. биол. 2000. — Т. 129. — Прил. 1. — С. 50−52.
- П.Фрейдин М. Б. Генетические основы подверженности к бронхиальной астме.//Генетика-2002. Т.5 С.25−37.
- Фрейдин МБ., Пузырев В. П., Огородова Л. М., с соавт. Полиморфизм генов интерлейкипов и их рецепторов: популяционная распространенность и связь с атопической бронхиальной астмой.// Генетика. 2002. — Т. 38.- № 12. С. 89−96.
- Хаитов Р. М., Богова А. В., Ильина Н. И. Эпидемиология аллергических заболеваний в России.// Иммунология. 1998. -№ 3. — С. 4−9.
- Чучалин А.Г. Бронхиальная астма. «Русский врач» 2001. -С. 144
- A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on Genetics of Asthma.// Nat Genet 1997. — V. 15 — P. 389−392.
- Abe E., De Waal Maleiyt R., Matruda L. el al. An 11-base-pair DNA sequence motif apparently unique to the interleukin 4 gene confers responsiveness to T-cell activation signals.// Proc. Natl. Acad. Sci. USA 1992.-V. 89.-P. 2864.
- Alberts B., Johnson A., Lewis S. Molecular biology of the Cell // J. Mol bio!.-2002. P. 858
- Anderson L.C., Beaty J.S., Nettles J.W., Seyfried C. E. et al. Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes.// J. Exp. Med. 1991,-V. 173. P. 181−183.
- Anderson G.G., Cookson W.O. Recent advances in the genetics of allergy and asthma.// Mol. Med. Today 1999. — V. 5. — P. 264−273.
- Arai N., Nomura D., Villaret D. et al. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. // J.Immunol. 1989. -V. 142(1). — P. 274−82.
- Barnes K.C., Marsh D.G. The genetics and complexity of allergy and asthma.// Immunol. Today 1998. — V. 19. — P. 325−332.
- Beaty J.S., West K.A., Nepom G.T. Functional effects of a natural polymorphism in the transcriptional regulatory sequence of HLA-DQB 1.// Mol. Cell. Biol. 1995 — V. 15. — P. 4771.
- Beghe B., Barton S., Rorke S. et al. Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population.// Clin Exp Allergy. -2003. V. 33 (8)-P. 1111−1117.
- Bleecker E.R., Meyers D.A. Genetics of allergy and asthma.// Allergy and allergic diseases Ed. A. B. Kay. Blackwell Science, Oxford. -1997. — P. 1196−1207.
- Borish L., Chipps B., Deniz Y. Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma.// Ann. Allergy Asthma Immunol. 2005. — V. 95 (3) — P. 247−253
- Broide D., Paine M.M., Firestein G.S. Eosinophils express interleukin 5 and granulocyte-macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.// J. Clin Invest. 1992. -V. 90. — P. 1414−1424.
- Brookes A. The essence of SNPs.// Gene-1999.-V.234(2) P. 177−186
- Bruhn K.W., Nelms K., Boulay J.L. et al. Molecular dissection of the mouse interleukin-4 promoter.// Proc Nat Acad Sci USA. 1993. — V. 90.-P. 9707−9711.
- Burchard E.G., SILverman E.K., Rosenwasser U., et al. Association between a sequence variant in the IL-4 gene promoter and FEV (1) in asthma.// Am J Respir Crit Care Med. 1999. — V. 160. P. 919−922.
- Cantrel D. T cell antigen receptor signal transduction pathways.// Annu. Rev. Immunol. 1996. — V. 14. — P. 259−274.
- Casolaro V., Georas S.N., Song D. et al. Inhibition of NF-AT-dependent transcription by NF-kB: Implications for differential cytokine expression.// Proc. AcadSci USA 1995. — V. 92. — P. 11 623.
- Ceresa B.P., Horvath C.M., Pessin J.E. Signal transducer and activator of transcription-3 serine phosphorylation by insulin is mediated by a Ras/Raf/MEK-dependent pathway. //Endocrinology. 1997. V. 138. -P. 4131−4137.
- Chand N., Harrison J.E., Rooney S. et al. Anti IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs.//Eur J Pharmacol. 1992. — V. 211. — P. 121−123.
- Choi E.H., Lee H.J., Yoo T. et al. A common haplotype of interleukin-4 gene is associated with severe respiratory syncytial virus disease in Korean children.//J.Infect. 2002. -V. 186. — P. 1207−1211.
- Chung K.F., Barnes P.J. Cytokines in asthma.// Thorax. 1999. -V. 54. — P. 825−857.
- Chung J., Uchida E., Grammer T.C. et al. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. // Mol. Cell Biol. -1997. -V. 17. P. 6508−6516.
- Claudia Sengler et al. Interactions between genes and environmental factors in asthma and atopy: new developments.// Respir. Res. 2002. — V. 3 (1).-P. 7−10.
- Clutterbuck E.J., Hirst E.M., Sanderson C.J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, 1L-3, IL-6 and GM-CSF.//Blood. 1989. — V. 73. — P. 1504−1512.
- Cookson W.O. The alliance of genes and environment in asthma and allergy.//Nature. 1999. — V. 402., Suppl. — B. 5−11.
- Cookson W.O., Sharp P.A., Faux J.A. et al. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome llq.//Lancet.- 1989. V. 112.-P. 1292−1295.
- Corry D.B., H.G., Folkesson M.L. et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.// J. Exp. Med. 1996. — V. 193. — P. 109.
- Crow S. Quarreling geneticists and a diplomat Genetics.// 1995. V. 140 (2).-P. 421−426.
- Daniels S.E., Bhattacharrya S., James A. et al. A genome-wide search for quantitative trait loci underlying asthma.// Nature. 1996. — V. 383.-P. 247−250.
- De Santis G.T. et al. A loose cage for transition metals.// Inorg. Chem. 1997. — V. 36 (10). — P. 1996−2001.
- Dubucquoi S., Desreumaux P., Janin A. et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion.// J Exp Med. 1994. — V. 179. P. 703−708.
- Duetsch G. et al. STAT6 as an asthma candidate gene: polymorphism-screening, association and haplotype analysis in a Caucasian sib-pair study.//Hum. Mol. Genet.-2002. V. 11(6). — P. 613−621.
- Elliott K, Fitzpatrick E., Hill D. et al. The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhood.//J AllergyClinImmunol.-2001 .-V. 108.- P. 285.
- Emery P.B., Mach, Reith W. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence.// Hum. Immunol. 1993. — V. 38. -P. 137.
- Endo T.A., Masuhara M., Yolcouchi M. et al. A new protein containing an SH2 domain that inhibits JAK kinases. // Nature. -1997.-V. 387.-P. 921−924.
- Falconer D.S. The inheritance of liability to certain diseases, estimated from the incidence among relatives.// Ann. Hum. Genet. -1965.-V. 29.-P. 51−76.
- Finlay G.A. et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema.// Am. J. Respir. Crit. Care Med. 1997. — V. 156. — P. 240−247.
- Foster P. S., Hogan S.P., Ramsay A.J. et al. IL-5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model.//J. Exp. Med. 1996. — V. 193. — P. 195.
- Gelfand E.W. et al. T lymphocytes: setting the tone of the airways.// Nat.Med. 1997. — V. 3 (4). — P. 382−383.
- Gonzalez F.A., Raden D.L. Davis R.J. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. // J.Biol.Chem. 1991. — V. 266. — P. 22 159−22 163.
- Gotoh A., Takahira H., Mantel C. et al Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines. // Blood. 1996. — V. 88. — P. 138−145.
- Graves P.E., Kabesch M., Halonen M. et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children.// J Allergy Clin Immun. 2000. — V. 105. — P. 506−513.
- Grunig G., Warnock M., Wakil A.E. et al. Requirement for IL-13 independently of IL-4 in experimental asthma.// Science. 1998. -V. 282. — P. 2261−2262.
- Hall I.P. Genetics and pulmonary medicine: asthma.// Thorax. 1999. — V. 54. — P. 65−69.
- Hamid Q., Azzawi M., Sun Ying et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.// J Clin Invest. 1991. — V. 87. — P. 1541−1548.
- Hautamaki R.D., Kobayashi D.K., Senior R.M. et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.// Science. 1997. — V. 277. — P. 2002−2004.
- Heinrich P.C., Behrmann I., Muller N.G. et al. // Biochem.J. 1998. -V. 334.-P. 297−314.
- Heinzmann A., Mao X.Q., Akaiwa M. Genetic variants of IL-13 signaling and human asthma and atopy.// Hum Mol Genet. 2000. -V. 9. — P. 549−559.
- Hershey G.K., Friedrich M.F., Esswein L.A. et al. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor.// N Engl J Med. 1997. — V. 337. — P. 17 201 725.
- Hershey G.K.K. IL-13 receptors and signaling pathways: an evolving web // J. Allergy Clin.Jmmunol. 2003. — V. 111 (4). — P. 677−90.
- Hijazi Z., Haider. M.Z. Interleukin-4 gene promoter polymorphism C590T. and asthma in Kuwaiti Arabs.// Int Arch All Immun. 2000. — V. 122. — P. 190.
- Jarvis D., Burney P. Epidemiology of atopy and atopic diseases // Oxford Press 1997. — P. 1208−1224.
- Jin Y., Chen C., Xu Y. et al. Genetic epidemiological study of asthma in general. // Wei Sheng Yan.Jiu. 1998. — V. 27(1). — P. 29−31.
- Kabesch M., Baldini M., Graves PE., et al. Complete screening of the IL-4 gene and its flanking region for novel polymorphisms. // Am.Jour.Resp.Crit.Care Medicine. 2000. — V. 161(3). — P. A929.
- Kawashima T., Noguchi E., Arinami T. et al. Linkage and association of an inteiieukin 4 gene polymorphism with atopic dermatitis in Japanese families. // J Med Gene 1998. — V. 35. P. 502−504.
- Keatings VM., O’Connor BJ., Wright LG. et al. Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum. // J Allergy Clin Immunol -1997.-V. 99.-P. 693−698.
- Kita H., Gleich G.J. Chemokines active on eosinophils. Potential roles in allergic inflammation. // J. Exp. Med. 1996. — V. 193. — P. 24 212 426.
- Kruse S., Japha T., Tedner M. et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor a gene are associated with atopy and influence the signal transduction. // Immunology 1999. — V. 96. -P. 365−371.
- Kumar G., Gupta S., Wang S. et al. Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line // J.Immunol. 1994. — V. 153. — P. 4436−4447.
- Lacour F. cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. // Int.Immunol. 1994. — V. 6(9) — P. 1333−1342.
- Lamb P., Seidel HM., Haslam J. et al STAT protein complexes activated by interferon-gamma and gpl30 signaling molecules differ in their sequence preferences and transcriptional induction properties. //Nucleic.Acids.Res. 1995. — V. 23. — P. 3283−3289.
- Laitinen T., Kauppi P., Ingatius J. et al. Genetic control of serum IgE levels and asthma: Linkage and linkage disequilibrium studies in an isolated population. // Hum. Mol. Gen. 1997. — V. 6. — P.2069−2076
- Lander E.S., Schork N.J. Genetic dissection of complex traits. // Science. 1994. -V. 265. — P. 2037−2047.
- Li-Weber, M., Eder A., KralTt-Czepa H. et al. T cell-specific negative regulation of transcription of the human cytokine IL-4. // J. Immunol. 1992. — V.148. — P. 1913.
- Li-Weber M., Laur O.J., Davydov V.C. et al. What controls tissue-specific expression of the IL-4 gene? // Immunobiology 1997. — V. 198. — P. 170−178.
- Li-Weber M., Kramer P. H. Regulation of IL-4 gene expression by T cells and therapeutic perspectives. // Nat.Rev.Immunol. 2003. — V. 3(7). — P. 534−43.
- Li-Weber M., Davydov I.V., Krafft, H. et al. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression // J.Immunol. 1994. -V. 153(9)-P. 4122−33
- Li-Weber M., Salgame P., Hu C. et al. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter // J.Immunol. 1998. -V. 161(3)-P. 1380−9
- Lim CP., Cao X Regulation of Stat3 activation by MEK kinase 1 -J.Biol.Chem. 2001 276(24) 21 004−11
- Lim CP., Cao X. Serine phosphorylation and negative regulation of Stat3 by JNK // J.Biol.Chem. 1999. — V. 274. — P. 3 1055−31 061.
- Liu X., Nickel R., Beyer K. et al. An IL 13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). // J. Allergy Clin Immunol 2000. — V. 106.-P. 167−170.
- Lopez AF., Begley CG., WILliamson DJ. et al. Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. // J Exp Med 1986. — V. 163. — P. 1085−1099.
- Lopez AF., Sanderson CJ., Gamble JR., et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. // J Exp Med 1988. — V. l67. — P. 219−224.
- Mauser PJ., Pitman A., Witt A. et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. // Am Rev Respir Dis 1993. — V. 148. — P. 1623−1627.
- Mauser PJ., Pitman AM., Fernandez X. et al. Effects of an antibody to interleukin-5 in a monkey model of asthma. // Am J Respir Crit Care Med 1995. — V. 152. — P. 467−472.
- Marsh DG., Neely JD., Breazeale DR. et al: Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. // Science 1994. — V. 264. — P. 1 152−1156.
- Meyers D. A., Postma D. S., Panhuysen C. I. M. et al. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5 // Genomics 1994. — V. 23. — P. 464−470.
- Meyers D. A. New approaches to understanding the genetics of asthma // Immunol. Allergy Clin.North Am. 2005. — V.25(4). — P. 743−55.
- Mitsuyasu H., Izuhara K., Mao X.Q. et al. ILe50Val variants or IL4Ra upregulates IgE synthesis and associates with atopic asthma //Nature Genet. 1998, — V. 19.-P. 119−120.
- Mitsuyasu H., Yanagihara Y., Mao X.Q. et al. Dominant effect of ILe50Val variant of the human IL-4 receptor a-chain in IgE synthesis //J. Immunol. 1999. — V. 162.-P. 1227−1231.
- Miyajima A., Kitamura T., Harada N. et al. Cytokine receptors and signal transduction // Annu.Rev.Immunol. 1992. — V. 10. — P. 295 331.
- Moffatt MF., Schou C., Faux JA. Et al. Germline TCR-A restriction of immunoglobulin E responses to allergen. // Immunogenetics -1997. -V. 46. P. 226−230.
- Naka T., Narazaki M., Hirata M. et al. Structure and function of a new STAT-induced STAT inhibitor // Nature-1997.-V.387.-P.924−29.
- Ng J., Cantrell D. STAT3 Is a Serine Kinase Target in T Lymphocytes. IL-2 and T cell antigen receptor signals converge upon BiyKiiiTy 727 // J.Biol.Chem. 1997. — V. 272. — P. 24 542−24 549.
- Nagarkatti R., Kumar R., Sharma SK. et al. Association of IL4 gene polymorphisms with asthma in North Indians. // Int Arch Allergy Immunol 2004 — V. 134. — P. 206−212
- Noguchi E., Shibasaki M., Arinami T. et al: Evidence for linkage between asthma/atopy in childhood and chromosome 5q31.1-q33 in Japanese. // Am J Respir Crit Care Med 1997. — V. 156. — P. 13 901 393.
- Noguchi E., Shibasaki M., Arinami T. et al: Association of asthma and the interleukin-4 promoter gene in Japanese. // Clin Exp Allergy -1998.-V. 28.-P. 449−453.
- Noguchi E., Shibasaki M., Arinami T. et al. Lack of association of atopy/asthma and the interleukin-4 receptor a gene in Japanese // Clin. Exp. Allergy 1999. — V. 29. — P. 228−233.
- Noguchi E., Shibasaki M., Arinami T et al. No association between atopy/asthma and the Ue50Val polymorphism of IL-4 receptor. // Am J Respir Crit Care Med 1999. — V. 160. — P. 342−345.
- Paul W.E., Seder R.A. Lymphocyte response and cytokines. // Cell. 1994.-V. 76.-P. 241−251.
- Patuzzo C., Trabetti E., Malerba G. et al. No linkage or association of the IL-4Ralpha gene Q576R mutation with atopic asthma in Italian famlLies. // J Med Genet. 2000. — V. 37. — P. 382−384.
- Pellegrini S., Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs) // Eur.J.Biochem. 1997. — V. 248. — P. 615−633.
- Polvi A., West A., Kinos R. et al. Development of Asthma-Immuno Chip for gene expression studies of asthma and other immune mediated diseases. // Am. J. Hum. Genet. 2000. — V. 67- P. 382.
- Postma D.S., Bleecker E.R., Amelung P.J. et al. Genetic susceptibility to asthma bronchial hyperresponsiveness coinherited with a major gene for atopy.// N.Eng.J.Med.-l995.-V.333-P.894−900.
- Renauld J-C. New insights into the role of cytokines in asthma. // J Clin Pathol. 2001. — V. 54. — P. 577−589.
- Ricci M., Matucci A., Rossi O. Pathogenetic mechanisms and genetic aspects of bronchial asthma. // ACI International. 1997. -V. 9.-P. 141−148.
- Rooney J.W., Hoey T., Glimcher L.H. The Proximal promoter of the IL-4 gene is composed of multiple essential regulatory sites that bind at least two distinct factors. // Immunity. 1995. — V. 2. — P. 473.
- Rooney J.W., Hodge M.R., McCaffrey P.G. et al. A common factor regulates both Thl- and Th2-specific cytokine gene expression. // EMBO J. 1994. — V. 13. — P. 625.
- Rosa-Rosa L., Zimmermann N., Bernstein J.A. et al. The R576 IL-4 receptor alpha allele correlates with asthma severity. // J Allergy Clin Immunol. 1999. — Y. 104. — P. 1008−1014.
- Rosenwasser L.J. The genetics of atopy. // Allergy. 1998. — V. 53 (46). — P. 8−11.
- Rosenwasser L.J., Klemm D.J., Dresback J.K. et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. // Clin Exp Allergy. 1995. — V.25 (2). — P. 74−78.
- Scarel-Caminaga R.M., TrevILatto P.C., Souza A.P. et al. Frequencies of the -330 (T -" G) IL-2 and -590 (T C) IL-4 gene polymorphisms in a population from south-eastern Brazil. // European Journal of Immunogenetics. 2001. — V. 29. — P. 293−296.
- Schindler C., Darnell-JE J. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. // Annu.Rev.Biochem. 1995. — V. 64. — P. 621−651.
- Schindler U., Wu P., Rothe M. Components of a Stat recognition code: evidence for two layers of molecular selectivity.// Immunity -1995. V. 2. — P. 689−697.
- Schreiber S.L., Crabtree G.R. The mechanisms of action of cyclosporin A and FK506. // Immunol Today. 1992. — V. 13. -P. 136−142.
- Sibbald B. Genetic bases of asthma. // Semin. Resp. Med. 1986. -V. 7. — P. 307−315.
- Shapiro S.D. Animal models for chronic obstructive pulmonary disease. Age of klotho and marlboro mice. Am. // J. Respir. Cell Mol. Biol. -2000. V. 22. — P. 4−7.
- Song Z., Casolaro V., Chen R. et al. Polymorphic nucleotides within the human 1L-4 promoter that mediate overexpression of the gene. // J Immunol. 1996. — V. 156. — P. 424−429.
- Starr R., WILlson T.A., Viney E.M. et al. A family of cytokine-inducible inhibitors of signaling. //Nature 1997.-V. 387.- P. 917−21.
- Stavnezer J. Antibody class switching. // Adv. Immunol. 1996. -V. 61. — P. 79−146.
- Stranick K.S., Zambas D.N., Uss A.S. et al. Identification of transcription factor binding sites important in the regulation of the human interleukin-5 gene. // J Biol Chem. 1997. V. 272. P. 1 645 316 465.
- Suzuki I., Hizawa N., Yamaguchi E., et al. Association between a C+33T polymorphism in the IL-4 promoter region and total serum IgE levels. // Clin Exp Allergy 2000. — V. 30 — P. 1746−1749.
- Suzuki 1., Yamaguchi E., Hizawa N. et al. A new polymorphism in the 5' flanking region of the human interleukin (IL)-4 gene. // Immunogenetics. 1999. — V. — 49. — P. 738−739.
- Symula D.J., Frazer K.A., Ueda Y. et al. Functional screening of an asthma QTL in YAK transgenic mice. // Nature Genet. 1999. — V. 23.- P. 241−244.
- Szabo S.J., Gold J. S., Murphy T. L., et al. Identification of cisacting regulator elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NFATc. // Mol. Cell. Biol. 1993. -V. 13. -P. 4793−4805.
- Takabayashi. A., Ihara. K., SasakiY. et. al. Novel polymorphism in the 5'-untranslated region of the interleukin-4 gene. // J. Hum.Genet. 1999.-V. 44.-P. 352−353.
- Takeda K., Akira S. STAT family of transcription factors in cytokine-mediated biological responses // Cytokine Growth Factor Rev. 2000. — V. 11. — P. 199−207.
- Trejaut J.A., Tsai Z.U., Lee H.L. Cytokine gene polymorphisms in Taiwan. // Tissue Antigens. 2004. — V. 64(4). — P. 492−499.
- Todd M.D., Grusby M.J., Lederer J.A. et al. Transcription of the Interleukin 4 Gene Is Regulated by Multiple Promoter Elements. // J. Exp. Med. 1993. — V. 177. — P. 1663−1674.
- Tokoyoda K., Tsujikawa K., Matsushita H. Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28~stimulated naive T cells. // Int.Immunol. 2004. — V. 16 (5). — P. 643−655.
- The Collaborative Study on the Genetics of Asthma. A genome-wide search for asthma susceptibility loci in ethnically diverse populations //Nature Genet. 1997. — V. 15. — P. 389−392.
- Walley A.J., Cookson W.O. Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. // J Med Genet. 1996. — V. 33. — P. 689.
- Walley A.J., Wiltshire S., Ellis C.M. et al. Linkage and allelic association of chromosome 5 cytokine cluster genetic markers with atopy and asthma associated traits. // Genomics. 2001. — V. 72 (1). -P. 15−20.
- Walker C.E., Bode L., Boer T.T. et al. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. // Am. Rev. Respir. Dis. 1992. — V. 146. — P. 109−112.
- Walker C., Jr J.C., Virchow P.L. et al. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. //J. Immunol. 1991. — V. 146. — P. 1929−1932.
- Wenner C.A., Szabo S.J., Murphy K.M. Identification of IL-4 promoter elements conferring Th2-restricted expression during Thelper cell subset development. // J. Immunol. 1997. — V. 158. -P. 765−773.
- Wills-Karp M., Luyimbazi J., Xu X. et al. Interleukin-13: central mediator of allergic asthma.// Science. 1998.-V. 282.-P. 2258−2261.
- Woolcock A.J., Peat J.K. Evidence for the increase of asthma worldwide // The rising trends in asthma Ed. D. Chadwick, G. Cadrew. J. WILey & Sons, Chichester. — 1997. P. 122−139.
- Yamaguchi Y., Hayashi Y., Sugama Y. et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil factor. // J Exp Med. 1988. -V. 167. — P. 1737−1740.
- Yan L., Galinsky R.E., Bernstein J.A. et al. Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. // Pharmacogenetics. 2000. -V. 10.-P. 261−266.
- Zhang Y., Lefort J., Kearsey V. et al. A genome-wide screen for asthma-associated quantitative trait loci in a mouse model of allergic asthma. //Hum. Mol. Genet. 1999. — V. 8. — P. 601−605.
- Zheng T., Zhu Z., Wang Z. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. / J. Clin. Invest. 2000. — V. 106(9). — P. 1081−1093.
- Zheng T., Zhu Z., Liu W. et al. Cytokine regulation of IL-13Ralpha2 and IL-13Ralphal in vivo and in vitro. // J. Allergy Clin. Immunol.2003. -V. 11 (4). P. 720−728.
- Zhou G., Zhai Y., Dong X. et al. Haplotype structure and evidence for positive selection at the human IL13 locus. // Mol.Biol.Evol.2004. V. 21 (1). — P. 29−35.
- Zhu Z, Homer R.J., Wang Z. et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. // J Clin Invest. 1999. — V. — 102. — P. 779−788.
- Zhu Y., Chen L., Huang Z. et al. IL-5 primes Th2 cytokine-producing capacity in eosinophils through a STAT5-dependent mechanism. // J. Immunol. 2004. — V. 173 (5) — P. 2918−2922.
- Zhu Z., Lee C.G., Zheng T., Chupp G. et al. Airway inflammation and remodeling in asthma. Lessons from interleukin 11 and interleukin 13 transgenic mice. // Am. J. Respir. Crit Care Med. -2001. V. 164 (10). — P. 67−70.